So MSB was at this price in May 2007, but now has
1. reduced mortality in CHF (II) patients by 60% (should now be over $10/share imho)
2. showed efficacy in sr-aGvHd (odac 9:1)
3. High probability of reduced mortality in Covid19 ARDS patients after best SOC. Result pending.
4. Partner in Novartis & others lining up???
This stock seems cheap to me because I see that the product .... MSC’s work.
yes there is risk, but I see the hurdles being overcome soon.
YZ
MSB Trading 2021 - paradigm shift, page-19
-
- There are more pages in this discussion • 10,192 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.03 |
Change
-0.040(3.76%) |
Mkt cap ! $1.170B | |||
| Open | High | Low | Value | Volume |
| $1.07 | $1.07 | $1.01 | $13.19M | 12.81M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 61090 | $1.02 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.03 | 239558 | 5 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |